Oxford BioDynamics's market cap is currently £6.36M. The company's EPS TTM is p-0.007; its P/E ratio is -0.11; Oxford BioDynamics is scheduled to report earnings on June 30, 2025, and the estimated EPS forecast is p―. See an overview of income statement, balance sheet, and cash flow financials.
